337 related articles for article (PubMed ID: 30509387)
1. Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity.
Piconese S; Cammarata I; Barnaba V
J Autoimmun; 2018 Dec; 95():58-68. PubMed ID: 30509387
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
Wong MT; Chen SS
Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
[TBL] [Abstract][Full Text] [Related]
3. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
4. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
Zhang Z; Zhang JY; Wang LF; Wang FS
J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
[TBL] [Abstract][Full Text] [Related]
5. Understanding the host genetics of chronic hepatitis B and C.
Thursz M; Yee L; Khakoo S
Semin Liver Dis; 2011 May; 31(2):115-27. PubMed ID: 21538279
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity against hepatitis C virus.
Xu Y; Zhong J
Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of hepatitis B and C virus envelope glycoproteins.
Jeulin H; Velay A; Murray J; Schvoerer E
World J Gastroenterol; 2013 Feb; 19(5):654-64. PubMed ID: 23429668
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.
Marusawa H; Osaki Y; Kimura T; Ito K; Yamashita Y; Eguchi T; Kudo M; Yamamoto Y; Kojima H; Seno H; Moriyasu F; Chiba T
Gut; 1999 Aug; 45(2):284-8. PubMed ID: 10403743
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies of hepatitis B and C.
Chen RY; Desmond PV; Locarnini SA
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S471-81. PubMed ID: 12534781
[No Abstract] [Full Text] [Related]
10. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
Wang FS; Zhang Z
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression.
Khanam A; Chua JV; Kottilil S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071064
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma.
Ailioaie LM; Litscher G
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998270
[TBL] [Abstract][Full Text] [Related]
13. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
Ishibashi M; Yamaguchi H; Hirotani Y; Sakurada A; Endo T; Sugitani M; Takayama T; Makishima M; Esumi M
Arch Virol; 2018 Apr; 163(4):855-865. PubMed ID: 29248968
[TBL] [Abstract][Full Text] [Related]
14. [IMMUNOPATHOGENESIS OF OCCULT INFECTION CAUSED BY HEPATITIS B VIRUS].
Semenenko TA; Suslov AP
Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):105-13. PubMed ID: 26950999
[TBL] [Abstract][Full Text] [Related]
15. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
16. Role of antiviral therapy in the management of hepatocellular carcinoma.
Guan YS; He Q
Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
[TBL] [Abstract][Full Text] [Related]
17. Role of Some Predominant Host Immunomodulators' Single Nucleotide Polymorphisms in Severity of Hepatitis B Virus and Hepatitis C Virus Infection.
Rehman SU; Rauf M; Abbas Z; Hamed MH; Qadri I
Viral Immunol; 2016 Dec; 29(10):536-545. PubMed ID: 27676210
[TBL] [Abstract][Full Text] [Related]
18. HBV + HCV = HCC?
Cramp ME
Gut; 1999 Aug; 45(2):168-9. PubMed ID: 10403725
[No Abstract] [Full Text] [Related]
19. Sister chromatid exchange and mitotic index in patients with cirrhosis related to hepatitis B and C viruses and in chronic carriers.
Ucur A; Palanduz S; Cefle K; Ozturk S; Tutkan G; Vatansever S; Erden S; Karan MA; Erten N; Guler K; Tascioglu C
Hepatogastroenterology; 2003; 50(54):2137-40. PubMed ID: 14696481
[TBL] [Abstract][Full Text] [Related]
20. Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.
Pagliaccetti NE; Robek MD
J Interferon Cytokine Res; 2010 Aug; 30(8):585-90. PubMed ID: 20645875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
